Division of Neurosurgery, Santobono-Pausilipon Children's Hospital, Via Mario Fiore 6, 80121, Naples, Italy.
Division of Pediatric Neuroradiology, Santobono-Pausilipon Children's Hospital, Via Mario Fiore 6, 80121, Naples, Italy.
Childs Nerv Syst. 2021 Jul;37(7):2187-2195. doi: 10.1007/s00381-021-05057-3. Epub 2021 Jan 28.
Desmoplastic infantile astrocytomas and gangliogliomas (DIA/DIG) usually present with a large size, large cystic component, large dural implant, encasement of big vessels, clinical presentation within 18 months of life, high incidence of seizures and overall good prognosis, even if tumour surgery can be very challenging at first procedure.
We retrospectively reviewed clinical and radiological data of patients diagnosed with desmoplastic infantile tumours who were surgically treated between 2008 and 2019.
The series included 12 patients. The median age at surgery was 91 days. The average tumour volume was 212 cm. Cystic components were predominant ranging from 0 to 295 cm. Active hydrocephalus was pre-operatively evident in 5 cases. Eight patients (66.6%) received total or subtotal removal, three of them (25%) underwent partial removal, and one patient (8.3%) received a biopsy. One patient died within 24 h after surgery due to severe hypotension, as a consequence of significant intraoperative blood loss. Overall, seven (58.3%) patients were reoperated on the tumour after the first procedure: 4 patients were operated twice; 3 patients were operated 3 times. Two patients presented remote localizations and underwent chemotherapy. At last follow-up, 7 patients were tumour-free, 2 are alive with stable disease, and 2 are alive with progressive disease (leptomeningeal seeding).
Desmoplastic infantile tumours are rare giant neonatal tumours. Total removal is the goal of treatment, but prognosis remains good even if total removal is not achieved. In case of tumour progression or epilepsy from residual tumour, reoperation is the first option, with chemotherapy reserved to unresectable or disseminated cases with mixed results, while, to date, radiotherapy still plays no role.
促纤维增生型婴儿型星形细胞瘤和节细胞胶质瘤(DIA/DIG)通常表现为体积大、囊性成分大、硬膜内种植大、大血管包绕、18 个月内发病、癫痫发生率高、总体预后良好,即使肿瘤手术难度较大。
我们回顾性分析了 2008 年至 2019 年手术治疗的促纤维增生型婴儿肿瘤患者的临床和影像学资料。
本系列包括 12 例患者。手术时的中位年龄为 91 天。平均肿瘤体积为 212cm³。囊性成分占主导地位,范围从 0 到 295cm³。5 例术前有活动性脑积水。8 例(66.6%)患者接受了全切或次全切除,其中 3 例(25%)行部分切除,1 例(8.3%)行活检。1 例患者术后 24 小时内死于严重低血压,术中失血较多。总体而言,7 例(58.3%)患者在第一次手术后对肿瘤进行了再次手术:4 例患者进行了 2 次手术;3 例患者进行了 3 次手术。2 例患者出现远处局部转移,接受了化疗。末次随访时,7 例患者肿瘤无残留,2 例患者疾病稳定,2 例患者疾病进展(软脑膜播散)。
促纤维增生型婴儿型肿瘤是罕见的新生儿期巨大肿瘤。完全切除是治疗目标,但即使未完全切除,预后仍然良好。如果肿瘤进展或残留肿瘤引起癫痫,再次手术是首选,化疗保留给无法切除或播散的病例,效果不一,而放疗目前仍无作用。